Who invested in Drive Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$75Kraised across 1 round since 2022, from 1 source

Latest round: Grant, $75KSept 2022
Investors: 3

See who backed them

The rounds

Sept 2022
Grant$75K
Source recorded

Founders and team

From Drive Therapeutics's own website: 2 on the team.

Doug GoodingChief Executive Officer
Ryan QuickChief Operating Officer

Everyone who backed them

National Science FoundationGovernment1round

One North Carolina Small Business ProgramInvestment firm1round

North Carolina Biotechnology CenterGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Drive Therapeutics

Who invested in Drive Therapeutics?

Drive Therapeutics's investors include National Science Foundation, One North Carolina Small Business Program and North Carolina Biotechnology Center.

How much has Drive Therapeutics raised?

Drive Therapeutics has raised $75K across 1 round since 2022.

When did Drive Therapeutics last raise?

Drive Therapeutics's most recent round was a Grant of $75K in Sept 2022.

What was Drive Therapeutics's biggest round?

Its most recent round, $75K in Sept 2022, is also its largest on record.

Who backed Drive Therapeutics first?

Drive Therapeutics's first round on record, in Sept 2022, was backed by National Science Foundation, One North Carolina Small Business Program and North Carolina Biotechnology Center.